Scribe announced its initial research collaboration with Sanofi for CRISPR-based cell therapies to address oncology ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

Editas Medicine ( (EDIT) ) has provided an announcement. Editas Medicine announced new in vivo preclinical proof of concept data and outlined its strategic priorities and key milestones for 2025, ...

And yet, data science is now poised to usher in a level and acceleration of progress that even life sciences have never ...

Intellia Therapeutics, Inc. NTLA lost 21.6% in a week as investors were disappointed with the company’s plans for portfolio ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

In theory, CRISPR gene editing could be used to make any modification to the DNA of virtually any living being. While we think first of editing the human genome to cure diseases, CRISPR could play an ...

ON CRISPR enzyme, will combine with RNA guides for pharma customers. Deal follows HuidaGene agreement, offers 99% cost ...